Wigen Biomedicine Technology (shanghai) Co., Ltd.

Conopco, Inc.

Delta Electronics, Inc.

Chinese Academy of Sciences

Espressif Systems (shanghai) Co., Ltd.

Suzhou Suplead Life Sciences Co., Ltd.

Unilever Plc

Unilever, N.v.

Unilever IP Holdings B.v.

Unilever Global IP Limited

Unilever Plc, a Company Registered in England and Wales Under Company No. 41424

Yuanyuan Zhang

Hualiang Jiang

Cheng Luo

Kaixian Chen

Wei Wan

Liyan Yue

Yuli Xie

Xiaoyun Pan

Bing Zhou

Zhiyi Yao

Jianping Ying

Christopher Clarkson Jones

Jianhong Zeng

Yan Wu

Craig Warren Jones

Aibin Qiu

Jinfang Wang

Kun Wei

Yaxi Yang

Gang Qiao

Xinjun Wang

Kenneth Stuart Lee

Changxi Li

Junyi Zhang

Bidong Zhang

Daohai Du

Shengdong Gu

Provided is a method sending an acknowledgment frame, wherein by receiving a data frame sent by the first access point and calculating the minimum transmission power of the present station, the maximum transmission power of the station is used as the initial transmission power; the pre-established queue of the maximum transmission powers of the overlapping basic service set is invoked; the queue is a set of maximum transmission powers which does not affect packet reception of one or more second stations and calculated by the first station; the maximum transmission power of the overlapping basic service set allowed in the pre-established queue is traversed sequentially; being greater than or equal to the minimum transmission power, the minimum value among the initial transmission power and one or more maximum transmission powers is taken as the final transmission power; and the acknowledgment frame is sent by using the determined final transmission power.

Method and apparatus for sending acknowledgement frame, station, and storage medium

The present invention relates to use of an aminomethylenecyclohexane-1,3-dione compound, more particularly to use of a compound shown in the following formula (I) or a pharmaceutically acceptable salt thereof alone or in combination with other drug in preparing a drug for regulating or treating a disease related to autophagy, especially mammalian ATG8 homologous proteins. 

Use of aminomethylenecyclohexane-1,3-dione compound

It is related to compounds used as autophagy modulators and a method for preparing and using the same, specifically providing a compound of general formula (I), or pharmaceutically acceptable salts thereof, which is a type of autophagy modulators, particularly mammalian ATG8 homologues modulators. 

Compound used as autophagy regulator, and preparation method therefor and uses thereof

The present invention provides an isoindolone-imide ring-1,3-dione-2-ene compound, and a preparation method, a pharmaceutical composition and use thereof. Specifically, the present invention provides a compound of Formula (I) below or a pharmaceutically acceptable salt thereof, wherein Ar is an isoindolinone-imide group represented by Formula (II), L is absent or is a divalent, trivalent or tetravalent linking group, and X is a group represented by Formula (III). Definitions of the other groups are as described in the specification. The compound of Formula (I) is an autophagy modulators, particularly a mammalian ATG8 homolog modulator. 

Class of isoindolone-imide ring-1,3-dione-2-ene compounds, composition and use thereof

The present invention provides a compound represented by formula I, pharmaceutically acceptable salts, enantiomers, diastereomers or racemates thereof, the preparation method thereof, the pharmaceutical composition comprising the same, and the use thereof in the preparation of a medicament for treating a disease or condition mediated by EED and/or PRC2. The compound of the present invention can be used treating PRC2-mediated diseases or conditions. 

Triazolopyrimidine, triazolopyridine compounds, and the composition thereof for treating PRC2-mediated diseases

Disclosed is a benefit agent delivery particle comprising a benefit agent; and a chitosan salt at the outer surface of the particle, wherein the chitosan salt comprises a chitosan component and amino acid anion, wherein the amino acid comprises phenylalamine; the amino acid does not comprises tyrosine; and the amino acid does not comprises histidine or the amino acid comprises no greater than 20% of histidine by mole of the total amino acid, wherein the benefit agent comprises fragrance, pro-fragrance, hair conditioning agent, anti-dandruff agent, moisturizers, emollients, dyes, pigments, color care additives, or a mixture thereof.

Benefit delivery particle comprising a phenylalanine chitosan salt

The invention provides improved deposition and reduced leakage benefits from a particle comprising: (a) a core comprising a benefit agent; (b) a shell, wherein the shell comprises a crosslinked, hydrophobically modified polyvinyl alcohol, which comprises a crosslinking agent comprising i) a first dextran aldehyde having a molecular weight of from 2,000 to 50,000 Da; and ii) a second dextran aldehyde having a molecular weight of from greater than 50,000 to 2,000,000 Da.

Encapsulated benefit agents

Provided is a flux regulation method for use in a power converter, wherein the method is carried out by a flux bias controller. The flux bias controller includes a current detector which is configured to detect the primary current of the transformer of the power converter in a predetermined switching cycle, a DC bias processor which is configured to obtain the duty ratio control signal according to the sampled primary current outputted from the current detector for a switching cycle later than the predetermined switching cycle, and a PWM controller which is configured to generate driving signals to control the on/off operations of the switching circuit of the power converter according to the duty ratio control signal, thereby suppressing the DC bias of the transformer by regulating the duty ratio of the switch circuit.

Power converter having flux bias regulation method

Growing community of inventors

Shanghai, China

Yuanyuan Zhang